https://charts.traderzeitung.de/phases/US03837C1062
string(1392) "{"isin":"US03837C1062","name":"Apyx Medical Corp","stock_id_xnas":8089158,"stock_id_xnys":null,"generated_at":"2026-08-09 08:02:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.16,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.13,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":-0.7212},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":4.06,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":-1.6949},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"
Apyx Medical Aktie News & Nachrichten

Apyx Medical Aktie News & Nachrichten

[WKN: A2PBJC | Symbol: APYX]
Realtimekurs
   
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

TOP-5-Kursziele der Analysten am 12.11.25

Innodata [US4576422053] BWS Financial bestätigt Buy-Rating mit Kursziel 110 USD (73 % Kurspotenzial)...

  • 1
MT Newswires 13.07.2026 13:24 Uhr

HC Wainwright nimmt die Coverage für Apyx Medical mit 'Kaufen'-Rating und einem Kursziel von $7 auf

07:23 AM EDT, 07/13/2026 (MT Newswires) -- Apyx Medical (APYX) hat ein durchschnittliches 'Kaufen'-Rating und ein mittleres Kursziel von $6,60, laut v